Eterna Therapeutics Inc Cash Flow Quality Index

Latest as of September 2018: 4.30x

Eterna Therapeutics Inc cash flow quality index. Eterna Therapeutics Inc (ERNA) has a Cash Flow Quality Index of 4.30x as of September 2018. Operating cash flow of $954.00 Million exceeds net income of $222.00 Million, indicating high earnings quality where cash backs reported profits. See Eterna Therapeutics Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

4.30x

Operating CF / Net Income

Operating Cash Flow

$954.00 Million

USD

Net Income

$222.00 Million

USD

Data as of

Sep 2018

Most recent filing

Eterna Therapeutics Inc Cash Flow Quality Index by Year (None–None)

Eterna Therapeutics Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Eterna Therapeutics Inc. For the full cash flow conversion analysis, see ERNA operating cash flow.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.